176 related articles for article (PubMed ID: 35062288)
1. A Functional Minigenome of Parvovirus B19.
Reggiani A; Avati A; Valenti F; Fasano E; Bua G; Manaresi E; Gallinella G
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062288
[TBL] [Abstract][Full Text] [Related]
2. A Parvovirus B19 synthetic genome: sequence features and functional competence.
Manaresi E; Conti I; Bua G; Bonvicini F; Gallinella G
Virology; 2017 Aug; 508():54-62. PubMed ID: 28500881
[TBL] [Abstract][Full Text] [Related]
3. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.
Xu P; Chen AY; Ganaie SS; Cheng F; Shen W; Wang X; Kleiboeker S; Li Y; Qiu J
J Virol; 2019 Jan; 93(1):. PubMed ID: 30282717
[TBL] [Abstract][Full Text] [Related]
4. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.
Ganaie SS; Chen AY; Huang C; Xu P; Kleiboeker S; Du A; Qiu J
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437973
[TBL] [Abstract][Full Text] [Related]
5. The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus.
Guan W; Wong S; Zhi N; Qiu J
J Virol; 2009 Sep; 83(18):9541-53. PubMed ID: 19587029
[TBL] [Abstract][Full Text] [Related]
6. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells.
Chen AY; Zhang EY; Guan W; Cheng F; Kleiboeker S; Yankee TM; Qiu J
Blood; 2010 Feb; 115(5):1070-80. PubMed ID: 19861680
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.
Gareus R; Gigler A; Hemauer A; Leruez-Ville M; Morinet F; Wolf H; Modrow S
J Virol; 1998 Jan; 72(1):609-16. PubMed ID: 9420265
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.
Luo Y; Kleiboeker S; Deng X; Qiu J
J Virol; 2013 Dec; 87(23):12766-75. PubMed ID: 24049177
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of human parvovirus B19 genotypes 2 and 3.
Chen Z; Guan W; Cheng F; Chen AY; Qiu J
Virology; 2009 Nov; 394(2):276-85. PubMed ID: 19758675
[TBL] [Abstract][Full Text] [Related]
10. RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers.
Wang J; Ganaie SS; Cheng F; Xu P; Ning K; Wang X; Kleiboeker S; Cheng S; Qiu J
mBio; 2020 Mar; 11(2):. PubMed ID: 32156816
[TBL] [Abstract][Full Text] [Related]
11. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
Bieri J; Ros C
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341051
[TBL] [Abstract][Full Text] [Related]
12. Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication.
Alvisi G; Manaresi E; Cross EM; Hoad M; Akbari N; Pavan S; Ariawan D; Bua G; Petersen GF; Forwood J; Gallinella G
Antiviral Res; 2023 May; 213():105588. PubMed ID: 36990397
[TBL] [Abstract][Full Text] [Related]
13. Antiviral effect of cidofovir on parvovirus B19 replication.
Bonvicini F; Bua G; Manaresi E; Gallinella G
Antiviral Res; 2015 Jan; 113():11-8. PubMed ID: 25446336
[TBL] [Abstract][Full Text] [Related]
14. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of brincidofovir on parvovirus B19.
Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
[TBL] [Abstract][Full Text] [Related]
16. Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.
Lou S; Luo Y; Cheng F; Huang Q; Shen W; Kleiboeker S; Tisdale JF; Liu Z; Qiu J
J Virol; 2012 Oct; 86(19):10748-58. PubMed ID: 22837195
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex.
Ganaie SS; Zou W; Xu P; Deng X; Kleiboeker S; Qiu J
PLoS Pathog; 2017 May; 13(5):e1006370. PubMed ID: 28459842
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Replication and Infection of Human Parvovirus B19.
Ganaie SS; Qiu J
Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.
Ning K; Roy A; Cheng F; Xu P; Kleiboeker S; Escalante CR; Wang J; Qiu J
J Virol; 2022 Jan; 96(2):e0132621. PubMed ID: 34669461
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 integration into human CD36+ erythroid progenitor cells.
Janovitz T; Wong S; Young NS; Oliveira T; Falck-Pedersen E
Virology; 2017 Nov; 511():40-48. PubMed ID: 28806616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
